X

pharmaceuticals

GMM Pfaudler Limited (GMMPFAUDLR) Q3 FY23 Earnings Concall Transcript

GMM Pfaudler Limited (NSE:GMMPFAUDLR) Q3 FY23 Earnings Concall dated Feb. 03, 2023. Corporate Participants: Priyanka Daga -- Deputy General Manager Tarak Patel -- Managing…

Divis Labs Ltd.(NSE:DIVISLAB )|Q3 FY23 Results Out|Total Income rises 5% yoy

Divi's Laboratories Limited (NSE: DIVISLAB) is a pharmaceutical company specializing in the manufacture of active pharmaceutical ingredients (APIs) and intermediates.…

Jubilant Pharmova Limited Q3 FY23; Revenue Increased By 18%

Jubilant Pharmova Limited (NSE: JUBLPHARMA) reported a Revenue from Operations of ₹1,533.22 Crores, a boost of 18% growth from the…

Alembic Pharmaceuticals Limited (APLLTD) Q3 FY23 Earnings Concall Transcript

Alembic Pharmaceuticals Limited (NSE:APLLTD) Q3 FY23 Earnings Concall dated Feb. 01, 2023. Corporate Participants: R.K. Baheti -- Director, Finance and Chief Financial…

Sun Pharmaceutical Industries Limited (SUNPHARMA) Q3 FY23 Earnings Concall Transcript

Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA) Q3 FY23 Earnings Concall dated Jan. 31, 2023 Corporate Participants: Abhishek Sharma -- Head of Investor…

Laurus Labs Limited Q3 FY23 Earnings Conference Call Insights

Key highlights from Laurus Labs Limited (LAURUSLABS) Q3 FY23 Earnings Concall Management Update: [00:03:57] LAURUSLABS said its strong results were…

Glenmark Life Sciences Limited Q3 FY23 Earnings Conference Call Insights

Key highlights from Glenmark Life Sciences Limited (GLS) Q3 FY23 Earnings Concall Q&A Highlights: [00:13:44] Tarang Agrawal of Old Bridge…

Laurus Labs Limited Q3 FY23; Consolidated Revenue Jumps By 50%

Laurus Labs Limited (NSE: LAURUSLABS) reported Revenue from Operations for Q3 FY23 of ₹1,544.82 Crore up from ₹1028.76 Crore year…

Torrent Pharmaceuticals Ltd Q3 FY23 Earnings Conference Call Insights

Key highlights from Torrent Pharmaceuticals Ltd (TORNTPHARM) Q3 FY23 Earnings Concall Management Update: [00:05:39] TORNTPHARM said the company expects to…

Torrent Pharmaceuticals Ltd (TORNTPHARM) Q3 FY23 Earnings Concall Transcript

Torrent Pharmaceuticals Ltd (NSE: TORNTPHARM) Q3 FY23 Earnings Concall dated Jan. 25, 2023 Corporate Participants: Sudhir Menon -- Executive Director, (Finance) and…